Clyde Biosciences Cardiomyocyte Assay
Home
Contact
Cardiac Safety Cardiac Drug Discovery
CellOPTIQ® Platform Evidence Assay Comparison
Services Overview Primary Screening Assay CiPA Assay Mechanistic CV Toxicity Heart Failure Assay hiPSC CMC Characterisation Voltage Assay Calcium Assay Contractility Assay In Silico Modelling Custom R&D
Working with Clyde Team News
Home Applications Cardiac Safety Cardiac Drug Discovery Technical CellOPTIQ® Platform Evidence Assay Comparison Services Services Overview Primary Screening Assay CiPA Assay Mechanistic CV Toxicity Heart Failure Assay hiPSC CMC Characterisation Voltage Assay Calcium Assay Contractility Assay In Silico Modelling Custom R&D About Working with Clyde Team News
Clyde Biosciences Cardiomyocyte Assay
CellOPTIQ the leading cardiomyocyte assay
Contact

Clyde Biosciences Site Map

 

Home

 

Home page

 

Applications

Cardiac Safety

Cardiac Drug Discovery

 

Technical

CellOPTIQ® Platform

Evidence

Assay Comparison

 

Services

Services Overview

CiPA Assay

Mechanistic CV Tox Assay

Heart Failure Assay

hiPSC CMC Characterisation

Voltage Assay

Calcium Assay

Contractility Assay

In Silico Modelling

Custom R&D

 

About Clyde

Working With Us

Team

News & Publications

Contact Us

 

Find out more: info@clydebio.com +44 (0)1698 539920

Clyde Biosciences Limited
Bo'Ness Road,
Newhouse, Lanarkshire, Scotland, ML1 5UH,
United Kingdom
+44 (0)1698 539920 info@clydebio.com
Hours
Applications
Cardiac Safety Cardiac Drug Discovery
Technical
CellOPTIQ® Platform Evidence Assay Comparison
Services
CiPA Assay Mechanistic CV Tox Assay Heart Failure Assay hiPSC CMC Characterisation Voltage Assay Calcium Assay Contractility Assay In Silico Modelling Custom R&D
About Clyde
Working With Us Team News Contact Us

Site Map • Privacy and Cookie Policy
Clyde Biosciences © 2017-21 | Company registration No. SC418838. Registered office: BioCity Scotland, Bo'ness Road, Motherwell ML1 5UH